Latest perspectives
CarDiaLogue unites the passion for cardiology and diagnostics in an engaging dialogue.
This platform is the one stop content site for healthcare professionals passionate about cardiovascular disease management.
Latest perspectives
CarDiaLogue unites the passion for cardiology and diagnostics in an engaging dialogue.
It was our pleasure to meet Prof. Carolyn Lam from the National Heart Centre, Singapore, and discuss this significant study to learn how it is moving forward.
ADOPT is a prospective, multinational randomized open-label study conducted in APAC (Taiwan, China, India, Malaysia, and Singapore) aiming to include 2,400 adults with type 2 DM without known cardiovascular disease.
This trial is investigating whether intensive preventive therapy (high dose renin-angiotensin-aldosterone system inhibitors, beta-blockade, sodium-glucose co-transporter 2 inhibitors) among biomarker (NTproBNP) identified high-risk type 2 DM patients without pre-existing cardiovascular disease, may be associated with reduced cardiovascular events compared to standard of care.
I hope we will look back at 2020 as a year when COVID-19 taught us valuable lessons on how we can recognize the value of in vitro diagnostics and biomarkers.
Life Cycle Leader Cardiac & Critical Care, Women's Health and Personalized Healthcare, Roche Diagnostics
Mathias Egermark shares his thoughts on the burden of cardiovascular diseases, the impact of the corona crisis on the perception of diagnostics, and the willingness to adopt innovation. He also shares some personal events by which he will remember 2020.
Mathias Egermark discusses the opportunities to improve treatment efficiency and outcomes in cardiovascular disease management, using a combination of wet biomarkers and digital technology. He also shares his vision of the improvement of cardiac care in the future.
Listen to the interesting discussion between Prof. Christa Cobbaert (Leiden University Medical Centre), Prof. Christian Mueller (University Hospital of Basel) and Prof. Christian Zaugg (Roche Diagnostics).
Join the #CarDiaLogue today and sign up for updates.
CarDiaLogue brings you the latest insights and valuable perspectives from some of the sharpest minds in cardiology to complement your specialist skills.
proCardio is a unique scientific event in the field of biomarkers in cardiovascular medicine proCardio has been recognized as a highly successful and engaging scientific event featuring a world-class international faculty to discuss cardiac biomarkers. We communicate the latest evidence and clinical trial data related to the use of cardiac biomarkers.
Content hub dedicated for c-suite professionals/executive leaders and other decision makers in healthcare, specifically diagnostics. Platform which inspires our readers to solve healthcare transformation challenges in a new way.
Scientific educational portal for healthcare professionals passionate about cardiovascular disease management. Aiming to provide new horizons of diagnostics and digital advancements to partner physicians in improving patient outcomes in the Asia and the Pacific region.
